Schedule 13G ownership disclosure
Akebia Therapeutics Inc
Security class unavailable · CUSIP: 00972D105
Event date: 2020-10-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 17,698,113
- Percent of class
- 12.3500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-20-000435
- Form type
- SC 13G
- Filer
- Akebia Therapeutics, Inc.
- CIK
- CIK 1517022
- Filed
- Nov 10, 2020
- Reporting period
- Oct 30, 2020
- Description
- Schedule 13G beneficial ownership